Navigation Links
Vital Access Reports Live VWING Clinical Cases and SAVE Study Clinical Data Presentation at CiDA Conference
Date:10/30/2013

SALT LAKE CITY, Oct. 30, 2013 /PRNewswire/ -- Vital Access Corporation today announced that on Friday, October 25th, Dr. John Ross, MD, FACS performed live VWING Vascular Needle Guide implantation cases and Dr. William Jennings, MD, FACS presented clinical data from the pivotal U.S. SAVE study at the 2013 Controversies in Dialysis Access (CiDA) Meeting in San Francisco.

As part of the CiDA conference agenda, Dr. John Ross performed three VWING implantation cases at his surgical facilities in Orangeburg, South Carolina, two of which were broadcast live to a large audience of physicians. These three cases represent common challenges faced by patients and clinicians in achieving vascular access. The first case involved a cephalic vein arteriovenous fistula (AVF) exhibiting a short usable length, where the VWING was implanted to provide an additional cannulation site for the patient and to extend the usable length of the fistula. The second case involved a non-transposed brachiobasilic AVF where the VWING was implanted to allow cannulation of the fistula in its native position without having to transpose or elevate the vessel. The third case involved a deep radiocephalic vein AVF where the VWING was implanted to permit cannulation of the vessel in its current position and avoid a more-invasive surgical elevation procedure. In all three cases, the VWING was implanted to facilitate easier access to the fistula to allow for safe and effective dialysis treatment. Following the cases, Dr. Ross stated, "For the difficult to cannulate fistula, the standard of care may have been changed by the VWING."

Dr. William Jennings presented results from the recently completed U.S. SAVE study, an IDE pivotal trial of the VWING™ Vascular Needle Guide that supported the recent U.S. market clearance of the device. Dr. Jennings, who was a principal investigator for the SAVE study at the University of Oklahoma in Tulsa, also discussed VWING surgical techniques and cannulation practice. Dr. Jennings described his experience with the VWING, stating, "I expect the device will be an important option for vascular access surgeons. Non-usable fistulas were easily converted to a reliable vascular access quickly, using the VWING implanted in a relatively minor procedure.  Both patients and staff were very pleased with the outcomes."

Doug Smith, President and CEO of Vital Access, summarized the activities of the meeting, stating, "In addition to the live cases and scheduled SAVE study report, we were pleased to see the VWING discussed on several other occasions throughout the conference. The response during and after CiDA has been very encouraging."

About Vital Access™:

Vital Access Corporation is a privately held company located in Salt Lake City that designs and manufactures surgical and interventional technologies to improve vascular access for patients and caregivers. The VWING™ Vascular Needle Guide is commercially available in the U.S., Europe, Canada, and New Zealand. For more information, call 801-433-9390 or visit www.vital-access.com.

Contact: Doug Smith, 801-433-9390


'/>"/>
SOURCE Vital Access Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
2. The Largest Private Funder Of Melanoma Research Receives Vital Support From Activist Jeffrey Epstein
3. inVentiv Medical Management Forms Partnership with Vital Decisions
4. New Survey Affirms Compounding Pharmacies Vital Role in Public Health
5. Finesse Solutions Turns to HiveMind Marketing to Revitalize Website
6. Frost & Sullivan: Appropriate Channel Partners Vital in the Highly Fragmented Medical Devices Distribution Market in VITSK
7. Medical Devices 2013: A Frost & Sullivan Executive MindXchange- Sustaining the Vitality of the Industry and Your Company
8. Best Practices Involving Product Innovation and Creation of Value Vital for Customer Retention, Finds Frost & Sullivan
9. Frost & Sullivan: Clinical Trial-based Evidence Vital to Obtain Venture Capital Funding for Wireless Patient Monitoring Technologies
10. Frost & Sullivan: Government Support Vital to Encourage Venture Capital Investments in the North American Healthcare Industry
11. Competitive Pricing Vital in the Asia-Pacific Digital and Computed Radiography Market, Finds Frost & Sullivan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Eyevensys, a private biotechnology company ... expression technology that enables the safe, local, sustained production ... wide range of ophthalmic diseases, announces it has received ... Agency (MHRA) to advance its technology into clinical development. ... The EyeCET ...
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology:
(Date:4/23/2017)... (PRWEB) , ... April 23, 2017 , ... ... and managed services announced the achievement of Cisco Select certification and SMB specialization. ... the United States. , In earning the Select Certification, Altura fulfilled ...
(Date:4/22/2017)... , ... April 22, 2017 , ... The San Juan Capistrano summer camp ... parenting report outlining the need for summer camps to provide physical activities for all campers. ... Physical Activity In Summer Camps , With an increase in specialty camps that focus on ...
(Date:4/21/2017)... ... , ... Chicago plastic surgeon, Dr. Anil R. Shah, MD , has ... bony lump located on the forehead usually attributed to a facial fracture. Their appearance ... Dr. Shah has discovered an approach that is minimally invasive. He is an expert ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies ... project in the company’s esteemed VISION House demonstration project series. Manifesting the concept of ... of resources they need to live affordably and abundantly without unduly taxing the resources ...
(Date:4/21/2017)... Sterling, VA (PRWEB) , ... April 21, 2017 ... ... hosting its first weeklong campaign, AWARE: A Week of Addiction and Recovery Education, ... emerging evidence in treating and preventing substance use disorders. , The mission ...
Breaking Medicine News(10 mins):